Ophthalmic Co. Hits Ch. 11 With $64M Debt, Eyeing Sale
By Emily Lever · November 24, 2025, 11:24 AM EST
Clearside Biomedical, a company developing treatments for eye diseases, has filed for Chapter 11 protection in Delaware bankruptcy court with $64 million in debt, saying it will attempt to sell its...
To view the full article, register now.